Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ju2 | 1O0 | Genome polyprotein | 2.7.7.48 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4ju2 | 1O0 | Genome polyprotein | 2.7.7.48 | 1.000 | |
4jty | 1NV | Genome polyprotein | 2.7.7.48 | 0.686 | |
4ju1 | 1NZ | Genome polyprotein | 2.7.7.48 | 0.677 | |
4jvq | 1ML | Genome polyprotein | 2.7.7.48 | 0.647 | |
4jtw | 1NU | Genome polyprotein | 2.7.7.48 | 0.645 | |
3cj3 | SX4 | Genome polyprotein | 2.7.7.48 | 0.564 | |
2d3u | CCT | Polyprotein | / | 0.558 | |
2o5d | VR1 | Genome polyprotein | 2.7.7.48 | 0.552 | |
1nhv | 154 | Genome polyprotein | 2.7.7.48 | 0.532 | |
2gir | NN3 | Genome polyprotein | 2.7.7.48 | 0.528 | |
2j5x | GSP | ADP-ribosylation factor 6 | / | 0.489 | |
4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.469 | |
4m9a | FDA | Acyl-CoA dehydrogenase | / | 0.469 | |
3elm | 24F | Collagenase 3 | 3.4.24 | 0.468 | |
1lwl | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.467 | |
1kt3 | RTL | Retinol-binding protein 4 | / | 0.466 | |
4j36 | 1HR | Kynurenine 3-monooxygenase | / | 0.462 | |
4l4x | NDP | AmphI | / | 0.462 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.462 | |
1cqp | 803 | Integrin alpha-L | / | 0.461 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.461 | |
3pqb | VGP | Putative oxidoreductase | / | 0.460 | |
4do3 | 0LA | Fatty-acid amide hydrolase 1 | 3.5.1.99 | 0.459 | |
2vig | FAD | Short-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.1 | 0.458 | |
1szc | CNA | NAD-dependent protein deacetylase HST2 | 3.5.1 | 0.455 | |
4bva | T3 | Ketimine reductase mu-crystallin | 1.5.1.25 | 0.455 | |
4knz | CB3 | Thymidylate synthase | / | 0.455 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.454 | |
4iv2 | 1GR | Estrogen receptor | / | 0.454 | |
4rpg | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.454 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.454 | |
1sqv | UHD | Cytochrome b | / | 0.453 | |
3b9l | AZZ | Serum albumin | / | 0.453 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.453 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.451 | |
3n8w | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.451 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.451 | |
5iub | CLR | Adenosine receptor A2a | / | 0.451 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.450 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.450 | |
1bqo | N25 | Stromelysin-1 | 3.4.24.17 | 0.449 | |
1i6x | CMP | cAMP-activated global transcriptional regulator CRP | / | 0.449 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.449 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.449 | |
1fel | FEN | Retinol-binding protein 4 | / | 0.448 | |
1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
2p4i | MR9 | Angiopoietin-1 receptor | 2.7.10.1 | 0.448 | |
3ntg | D72 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.448 | |
3pcf | FHB | Protocatechuate 3,4-dioxygenase beta chain | 1.13.11.3 | 0.448 | |
4fk8 | FAD | Ferredoxin--NADP reductase | / | 0.448 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.448 | |
4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.448 | |
1ht8 | 34C | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.447 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.447 | |
2a84 | ATP | Pantothenate synthetase | 6.3.2.1 | 0.447 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.447 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.447 | |
3dhc | CYK | N-acyl homoserine lactonase AiiA | 3.1.1.81 | 0.447 | |
4wda | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.447 | |
1a8p | FAD | Ferredoxin--NADP reductase | / | 0.446 | |
2ij7 | TPF | Mycocyclosin synthase | 1.14.21.9 | 0.446 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
4nmd | FDA | Bifunctional protein PutA | / | 0.446 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.446 | |
4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.446 | |
1brp | RTL | Retinol-binding protein 4 | / | 0.445 | |
1kzj | CB3 | Thymidylate synthase | / | 0.445 | |
1xdd | AAY | Integrin alpha-L | / | 0.445 | |
2hqp | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.445 | |
3meg | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.445 | |
4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.445 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.445 | |
1bye | ATA | Glutathione S-transferase 1 | 2.5.1.18 | 0.444 | |
1eqh | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.444 | |
1jtu | LYB | Thymidylate synthase | / | 0.444 | |
1kt6 | RTL | Retinol-binding protein 4 | / | 0.444 | |
1l3i | SAH | Probable cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating) | / | 0.444 | |
4kwi | 1TJ | Reductase homolog | / | 0.444 | |
4l8u | 9AZ | Serum albumin | / | 0.444 | |
4xz3 | COA | Acyl-CoA synthetase (NDP forming) | / | 0.444 | |
3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
4aox | FAD | Steroid monooxygenase | / | 0.443 | |
4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.443 | |
1z7y | AA5 | Cysteine synthase 1 | 2.5.1.47 | 0.442 | |
2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.442 | |
2xvv | 9DN | Serum albumin | / | 0.442 | |
4ele | 31I | Dihydrofolate reductase | / | 0.442 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
2b0m | 201 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.441 | |
3e8x | NAP | BH1520 protein | / | 0.441 | |
3uhm | RFN | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.441 | |
4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.441 | |
4l9q | 9TP | Serum albumin | / | 0.441 | |
1dkf | BMS | Retinoic acid receptor alpha | / | 0.440 | |
2ayl | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.440 | |
2bxm | IMN | Serum albumin | / | 0.440 | |
2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.440 | |
4a6n | FAD | TetX family tetracycline inactivation enzyme | / | 0.440 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 |